Insight Molecular Diagnostics Inc. (IMDX) — Cash Flow Quality Index

Latest as of March 2023: -2.74x

Insight Molecular Diagnostics Inc. (IMDX) has a Cash Flow Quality Index of -2.74x as of March 2023. Operating cash flow of $-8.30 Million is below net income of $3.03 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Insight Molecular Diagnostics Inc. (IMDX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-2.74x

Operating CF / Net Income

Operating Cash Flow

$-8.30 Million

USD

Net Income

$3.03 Million

USD

Data as of

Mar 2023

Most recent filing

Annual Cash Flow Quality Index for Insight Molecular Diagnostics Inc. (None–None)

Year-by-year earnings quality comparison for Insight Molecular Diagnostics Inc..

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.